Atlas Trials

Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer

Clinical trial NCT05156892 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05156892
Sponsor
Anthony Joshua, FRACP
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2022-09-04
Primary completion
2026-01-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.